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ABSTRACT 
Making claims on the health effects of foods currently presents major challenges to 
nutrition science. As a case in point, oat β-glucan has been shown to deliver a number 
of health benefits, including an ability to lower cholesterol levels as well as reducing 
glucose and insulin responses to a meal.  These physiological functions are related to 
the viscosity and solubility of the β-glucan, with the viscosity a function of 
concentration and molecular weight.  Further, despite epidemiological evidence that 
high fibre diets are associated with lower levels of overweight and obesity in 
populations, and experimental evidence that fibre will “make you feel fuller for 
longer”, there is little evidence linking specific fibres with weight control.  Changes to 
regulations governing health claims in Australia and New Zealand are currently under 
review, and while they reflect European and other regional positions in allowing 
claims for β-glucan and cholesterol, they do not address other health benefits such as 
weight loss.  This thesis provides a novel approach to evidence based research in food 
by combining studies in food science, acute meal tests and longer term dietary 
interventions.  The hypothesis examined in this thesis is that overweight individuals 
following a nutritionally-balanced, energy-restricted diet including oat β-glucan will 
experience increased satiety and lose more weight than if they followed the same diet 
without the added β-glucan.   
Product development studies examined the effects of extrusion on the important 
physical attributes of β-glucan included in a ready-to-eat cereal product.  It did not 
prove difficult to produce a cereal that maintained β-glucan at high molecular weight 
(>1 million) and was viscous at high concentration (up to 5g β-glucan/cereal serve).  
Extrusion improved solubility which means the effects of downstream processing in 
this manner are likely to improve the physiological effects of β-glucan in cereals. 
Results of a meal-test study with fourteen subjects found that increasing doses of β-
glucan up to 5.5 g, decreased insulin levels (P=0.011)  and increased subjective 
satiety measured by visual analogue scales (P=0.039).  Increasing doses of β-glucan 
were correlated with increased plasma concentrations of cholecystokinin (CCK) and 
peptide Y-Y (PYY) (R2=0.970 and 0.994 respectively).  Food intake at a subsequent 
meal was decreased with inclusion of β-glucan in the earlier test meal, although the 
differences were not statistically significant. 
A 3-month randomised controlled trial of 66 overweight women was then conducted 
to investigate the effects of two different doses of β-glucan (5-6g or 8-9g) on weight 
loss within an energy-restricted regimen.  Outcome measures included weight loss 
and markers of appetite regulation (hormones) as well as changes in metabolic 
variables related to cardiovascular disease. All groups lost weight (approximately 5% 
of body weight) and showed a reduced waist circumference (P<0.001 for both).  The 
study sample also showed reductions in total cholesterol, LDL, HDL, leptin, PYY, 
glucagon-like-peptide-1 (GLP-1) values and an increase in CCK levels.  No 
significant differences were noted between the groups for all outcome values except 
fasting PYY levels (P=0.018) but levels did not correlate with increasing dose.   
Thus, the addition of oat β-glucan did not enhance the effect of energy restriction on 
weight loss in mildly overweight women, although large standard deviations in 
observed results, suggested that individual responsiveness makes elucidation of 
significant changes difficult.  Adding these results to the body of evidence, it seems 
that some evidence exists relating to β-glucan and satiety with the most likely 
mechanisms relating to changes in absorption of nutrients and resultant release of 
anorexigenic hormones.  There appears to be insufficient evidence to suggest the 
validity of a claim related to β-glucan and weight control.  Further research of this 
nature would build on the knowledge of the mechanisms of satiety elucidated here, 
and this would further investigate how β-glucan and other soluble fibres may help 
weight control over longer time frames. 
 
